SCHEMBL2722294

SCHEMBL2722294

CC(=O)CC[C@@H](N=C(c1ccccc1)c1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.73
SLC7A5 Q01650 1/20 0.36
CTSK P43235 1/20 0.35
LTA4H P09960 1/20 0.35
ALDH1A1 P00352 2/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
ADRB3 P13945 1/20 0.34
BTN3A1 O00481 1/20 0.34
MMP1 P03956 1/20 0.33
MMP3 P08254 1/20 0.33
MMP9 P14780 1/20 0.33
ITGA4 P13612 1/20 0.33
ITGB7 P26010 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PPARG P37231 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12766557 1.00 AAK1 (0.73) AAK1SLC7A5CTSKLTA4HALDH1A1
SCHEMBL2722298 1.00 AAK1 (0.73) AAK1SLC7A5CTSKLTA4HALDH1A1
SCHEMBL2723027 0.87 AAK1 (0.70) AAK1SLC7A5CTSKLTA4HALDH1A1
SCHEMBL2723025 0.87 AAK1 (0.70) AAK1SLC7A5CTSKLTA4HALDH1A1
SCHEMBL22754527 0.87 AAK1 (0.70) AAK1CTSKLTA4HALDH1A1ADRB2
SCHEMBL16116872 0.87 AAK1 (0.70) AAK1CTSKLTA4HALDH1A1ADRB2
SCHEMBL16116863 0.86 AAK1 (0.76) AAK1CTSKALDH1A1TSHRHSD17B10
SCHEMBL11938939 0.86 AAK1 (0.76) AAK1SLC7A5CTSKALDH1A1TSHR
SCHEMBL30777019 0.86 AAK1 (0.68) AAK1SLC7A5CTSKALDH1A1TSHR
SCHEMBL15192090 0.86 AAK1 (0.68) AAK1CTSKALDH1A1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2632917-B1 NOVEL PHASE TRANSFER CATALYSTS UNIV SINGAPORE (SG) 2016-04-20 EP disclosed
EP-2632917-A1 NOVEL PHASE TRANSFER CATALYSTS National University of Singapore (SG) 2013-09-04 EP disclosed
US-20130217889-A1 NOVEL PHASE TRANSFER CATALYSTS NATIONAL UNIVERSITY OF SINGAPORE (SG) 2013-08-22 US disclosed
WO-2012057709-A1 NOVEL PHASE TRANSFER CATALYSTS NATIONAL UNIVERSITY OF SINGAPORE (SG) 2012-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217889-A1 NOVEL PHASE TRANSFER CATALYSTS POLR2B, POLR1A, POLR2A AAK1 3710/4885SLC7A5 3471/4885CTSK 2152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.